(Alliance News) - Advanced Oncotherapy PLC on Thursday said it is on track for first patient treatment with its LIGHT proton therapy system by 2020 end.
Shares in the proton therapy systems developer were up 4.0% at 39.00 pence in afternoon trade.
The LIGHT system will be used to treat cancer and is being built at the Accelerator & Technology Centre in Daresbury, UK. By the end of 2019, all of the accelerating structures and hardware for the treatment room will be at the Daresbury site.
The patient positioning system used for LIGHT is complete and currently "undergoing factory quality assurance verification" and testing of the nozzle device used to control the direction of the proton beam "remains on track".
Advanced Oncotherapy Chief Executive Nicolas Serandour said: "With the initial hardware manufacturing process and technical design now validated, we remain committed to completing the verification and validation needed to ensure first patient treatment by the end of 2020. It is essential that this verification work is completed to the highest specifications to ensure a smooth journey towards regulatory clearance and wider commercial launch of the LIGHT system around the world."
Advanced Oncotherapy (AVO)